![Thomas Schenk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Thomas Schenk served as the Chief Medical Officer at ImpediMed Ltd. from 2022 to 2023.
Prior to this, he obtained undergraduate degrees from Cornell University and Jacobs School of Medicine & Biomedical Sciences.
Antiguos cargos conocidos de Thomas Schenk.
| Empresas | Cargo | Fin |
|---|---|---|
| IMPEDIMED LIMITED | Director Técnico/Científico/I+D | 26/09/2023 |
Formación de Thomas Schenk.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
3
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImpediMed Ltd.
 ImpediMed Ltd. Medical SpecialtiesHealth Technology Develops and distributes medical devices for use clinical assessment and monitoring of human disorders and diseases | Health Technology |
Jacobs School of Medicine & Biomedical Sciences
 Jacobs School of Medicine & Biomedical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Bolsa de valores
- Insiders
- Thomas Schenk
